More Company News

Arecor Therapeutics

Additional formulation agreement with Top 5 global pharma partner
14 Feb 2023Read More

Arecor Therapeutics

AT278 data published in Diabetes Care
30 Jan 2023Read More

Arecor Therapeutics

Business update
19 Jan 2023Read More

Arecor Therapeutics

AT307 transfers to Hikma
12 Jan 2023Read More

Arecor Therapeutics

Tetris Pharma launches Ogluo in Austria
04 Jan 2023Read More

Arecor Therapeutics

Tetris Pharma agreement with Syneos Health
12 Dec 2022Read More

Arecor Therapeutics

Second AT278 trial to commence in Type II diabetes
22 Nov 2022Read More

Arecor Therapeutics

Insulin product patents granted in Japan and South Korea
22 Nov 2022Read More

Arecor Therapeutics

Exclusive Specialty Hospital formulation collaboration
10 Nov 2022Read More

Arecor Therapeutics

Tetris Pharma launches Ogluo in Germany
01 Nov 2022Read More

1 2 3 4
Return to Arecor Therapeutics
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).